Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | TEAD4 | Q15561 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 6/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.38 |
| ▸ | RELA | Q04206 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | APP | P05067 | 2/20 | 0.36 |
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1060011 | 0.89 | ALDH1A1 (0.32) | ALDH1A1CYP3A4TSHRSMN1; SMN2TP53 | |
| SCHEMBL19547985 | 0.81 | ACHE (0.41) | TDP1ALDH1A1CYP3A4TSHRTEAD4 | |
| SCHEMBL28446566 | 0.78 | ALDH1A1 (0.44) | TDP1MAPK1ALDH1A1CYP3A4TSHR | |
| SCHEMBL8150674 | 0.78 | CA4 (0.39) | ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL1322780 | 0.77 | CYP3A4 (0.50) | ALDH1A1CYP3A4TSHRMAPTSMN1; SMN2 | |
| SCHEMBL2335338 | 0.75 | TDP1 (0.52) | TDP1MAPK1ALDH1A1CYP3A4TSHR | |
| SCHEMBL357605 | 0.75 | TDP1 (0.52) | TDP1MAPK1ALDH1A1CYP3A4TSHR | |
| SCHEMBL21086727 | 0.75 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL28447705 | 0.75 | TDP1 (0.39) | TDP1MAPK1ALDH1A1CYP3A4TSHR | |
| SCHEMBL11317761 | 0.73 | TDP1 (0.43) | TDP1MAPK1ALDH1A1CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12609210-B2 | Curable composition and cured body of same | TOKUYAMA CORPORATION (JP) | 2026-04-21 | — | — | US | disclosed |
| US-12434265-B2 | Coating method | TOKUYAMA CORPORATION (JP) | 2025-10-07 | — | — | US | disclosed |
| CN-114245812-B | Latex for bonding fibrous structures | 昕特玛德国有限公司 | 2024-08-23 | — | — | CN | disclosed |
| CN-115702176-B | Curable composition and cured product thereof | 株式会社德山 | 2024-05-03 | — | — | CN | disclosed |
| EP-4013819-B1 | LATEX FOR BONDING FIBER STRUCTURES | SYNTHOMER DEUTSCHLAND GMBH (DE) | 2024-01-24 | — | — | EP | disclosed |
| EP-3530804-B1 | LATEX BONDED TEXTILE FIBER STRUCTURE FOR CONSTRUCTION APPLICATIONS | SYNTHOMER DEUTSCHLAND GMBH (DE) | 2023-09-06 | — | — | EP | disclosed |
| US-20230260669-A1 | CURABLE COMPOSITION AND CURED BODY OF SAME | TOKUYAMA CORPORATION (JP) | 2023-08-17 | — | — | US | disclosed |
| EP-4183579-A1 | CURABLE COMPOSITION AND CURED BODY OF SAME | Tokuyama Corporation (JP) | 2023-05-24 | — | — | EP | disclosed |
| CN-115702176-A | Curable composition and cured product thereof | 株式会社德山 | 2023-02-14 | — | — | CN | disclosed |
| WO-2022239631-A1 | NOVEL TERMINAL-MODIFIED POLYPHENYLENE ETHER AND TERMINAL-MODIFIED POLYPHENYLENE ETHER COMPOSITION | 旭化成株式会社 | 2022-11-17 | — | — | WO | disclosed |
| US-6506537-B2 | Photopolymerization | JSR CORPORATION (JP) | 2003-01-14 | — | — | US | disclosed |
| US-20020012872-A1 | Radiation-sensitive resin composition | JSR CORPORATION (JP) | 2002-01-31 | — | — | US | disclosed |
| EP-1164433-A1 | Radiation-sensitive resin composition | JSR Corporation (JP) | 2001-12-19 | — | — | EP | disclosed |
| WO-1998045368-A1 | OLEFIN (CO-)POLYMER COMPOSITIONS AND METHOD OF PRODUCING THE SAME | CHISSO CORPORATION (JP) | 1998-10-15 | — | — | WO | disclosed |
| US-5698627-A | AN AQUEOUS SOLUTION OF A COPOLYMER OF AN ACRYLAMIDE, A VINYL COMPOUND HAVING A CATIONIC GROUP AND ANOTHER UNSATURATED COMPOUND PREPARED IN THE PRESENCE OF A POLYHYDROXY COMPOUND; FREENESS; RETENTION; HIGH STRENGTH | JAPAN PMC CORPORATION (JP) | 1997-12-16 | — | — | US | disclosed |
| US-5622784-A | WATERPROOFING; MODIFIED SILICON DIOXIDE THIN FILM | SEIKO EPSON CORPORATION (JP) | 1997-04-22 | — | — | US | disclosed |
| EP-0564004-B1 | A highly stereoregular polypropylene | CHISSO CORP (JP) | 1996-09-25 | — | — | EP | disclosed |
| EP-0564004-A1 | A highly stereoregular polypropylene | CHISSO CORPORATION (JP) | 1993-10-06 | — | — | EP | disclosed |
| US-5077341-A | Using coordination catalyst | CHISSO CORPORATION (JP) | 1991-12-31 | — | — | US | disclosed |
| EP-0404519-A2 | A process for producing a high-stiffness polypropylene | CHISSO CORPORATION (JP) | 1990-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12609210-B2 | Curable composition and cured body of same | UACA, MMAB, SMCHD1 | TDP1 2720/4885MAPK1 2426/4885ALDH1A1 2725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.